Silvan Turkcan
Stock Analyst at Citizens
(0.40)
# 4,241
Out of 5,169 analysts
3
Total ratings
n/a
Success rate
-6.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Silvan Turkcan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintains: Market Outperform | $15 → $17 | $9.93 | +71.20% | 1 | Mar 17, 2026 | |
| NTLA Intellia Therapeutics | Maintains: Market Outperform | $21 → $28 | $13.21 | +111.96% | 1 | Mar 3, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Market Outperform | $86 → $80 | $47.69 | +67.75% | 1 | Jan 30, 2026 |
Relay Therapeutics
Mar 17, 2026
Maintains: Market Outperform
Price Target: $15 → $17
Current: $9.93
Upside: +71.20%
Intellia Therapeutics
Mar 3, 2026
Maintains: Market Outperform
Price Target: $21 → $28
Current: $13.21
Upside: +111.96%
CRISPR Therapeutics AG
Jan 30, 2026
Maintains: Market Outperform
Price Target: $86 → $80
Current: $47.69
Upside: +67.75%